
Blockchain firm Nebula Genomics has signed a data access agreement with EMD Serono, the North American biopharmaceutical business of Merck KGaA
Blockchain firm Nebula Genomics has signed a data access agreement with EMD Serono, the North American biopharmaceutical business of Merck KGaA
The most important news, once a week. No spam.